AgeChem Venture Fund

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting

Business Model:

Revenue: $2.5M

Employees: 2-10

Rankings

Detailed AgeChem Venture Fund Information

Geographic Data

AgeChem Venture Fund headquarters map

Address: 1 Westmount Square

City: Montreal

State: quebec

Zip: H3Z 2P9

Country: CA

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$44M

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

The AgeChem Fund L.P. currently has $65 million under management and is seeking to invest in companies developing therapeutics targeting age-related diseases. Principally, AgeChem wishes to build a portfolio of Companies developing novel therapeutics to treat metabolic disorders (e.g. diabetes, obesity), cardiovascular diseases, cancers, diseases of the central nervous system (e.g. Alzheimer, Parkinson, insomnia), inflammatory diseases (e.g. rheumatoid arthritis, psoriasis), ophthalmic diseases and numerous other age-related diseases.

Contact Phone:
+15148497696

Contact Email:

Announced Date Company Transaction Money Raised
2/2010 Altair Therapeutics Series B 17M
9/2011 Medicago Post-IPO Equity 0
11/2009 Advitech Venture Round 2.5M
4/2011 Akebia Therapeutics Series B 0
9/2010 Alethia BioTherapeutics Series A 0
5/2014 Sorbent Therapeutics Series D 0
6/2011 Sorbent Therapeutics Series B 0
10/2007 Chlorion Pharma Venture Round 6M
2/2008 Ocera Therapeutics Series C 0
9/2010 Sorbent Therapeutics Series B 0
2/2011 Conatus Pharmaceuticals Series B 0
11/2012 Alethia BioTherapeutics Series B 0
11/2013 Aerpio Pharmaceuticals Series A 0
1/2008 Sonexa Therapeutics Series A 0
6/2013 Akebia Therapeutics Series C 0
5/2014 Sorbent Therapeutics Series D 0
11/2013 Aerpio Pharmaceuticals Series A 0
6/2013 Akebia Therapeutics Series C 0
11/2012 Alethia BioTherapeutics Series B 0
9/2011 Medicago Post-IPO Equity 0
6/2011 Sorbent Therapeutics Series B 0
4/2011 Akebia Therapeutics Series B 0
2/2011 Conatus Pharmaceuticals Series B 0
9/2010 Sorbent Therapeutics Series B 0
9/2010 Alethia BioTherapeutics Series A 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research